| 3693 |
1262: Apoptosis |
2391: Reduced fertility |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3694 |
2390: reproductive hormonal Imbalance |
2391: Reduced fertility |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3695 |
2388: photoproducts generate ROS |
2389: Altered steroidogenesis |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3696 |
2388: photoproducts generate ROS |
2363: Mito ROS dysfunction |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3697 |
1507: Activation of PPARγ |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Dec 3, 2025 |
Dec 3, 2025 |
None
|
| 3698 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
2394: Lower survival B lymphocytes |
Dec 3, 2025 |
Dec 3, 2025 |
1 AOP
|
| 3699 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
2395: Diminished proliferation of activated B lymphocytes |
Dec 3, 2025 |
Dec 3, 2025 |
1 AOP
|
| 3700 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
2396: Diminished differentiation of activated B lymphocytes |
Dec 3, 2025 |
Dec 3, 2025 |
1 AOP
|
| 3701 |
2396: Diminished differentiation of activated B lymphocytes |
2398: Reduced antibody production |
Dec 3, 2025 |
Dec 3, 2025 |
1 AOP
|
| 3702 |
2398: Reduced antibody production |
2397: Diminished vaccine response |
Dec 3, 2025 |
Dec 3, 2025 |
1 AOP
|
| 3703 |
2394: Lower survival B lymphocytes |
2395: Diminished proliferation of activated B lymphocytes |
Dec 3, 2025 |
Dec 3, 2025 |
1 AOP
|
| 3704 |
2395: Diminished proliferation of activated B lymphocytes |
2396: Diminished differentiation of activated B lymphocytes |
Dec 3, 2025 |
Dec 3, 2025 |
1 AOP
|
| 3705 |
26: Antagonism, Androgen receptor |
2393: AR transcriptional activity in GT tissues, reduced |
Dec 16, 2025 |
Apr 8, 2026 |
1 AOP
|
| 3706 |
2393: AR transcriptional activity in GT tissues, reduced |
2399: FGF10/FGFR2-IIIb signaling in genital tissue, reduced |
Dec 16, 2025 |
May 7, 2026 |
1 AOP
|
| 3707 |
2399: FGF10/FGFR2-IIIb signaling in genital tissue, reduced |
2400: Preputial epithelial morphogenesis, disrupted |
Dec 16, 2025 |
Jun 4, 2026 |
1 AOP
|
| 3708 |
2400: Preputial epithelial morphogenesis, disrupted |
2401: Male PPS, failed/delayed |
Dec 16, 2025 |
Dec 16, 2025 |
1 AOP
|
| 3709 |
2342: Fe-S cluster assembly, impaired |
178: Mitochondrial electron transport chain, disrupted |
Jan 7, 2026 |
Jan 7, 2026 |
1 AOP
|
| 3710 |
2341: TCA cycle, disrupted |
178: Mitochondrial electron transport chain, disrupted |
Jan 7, 2026 |
Jan 7, 2026 |
1 AOP
|
| 3711 |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Jan 16, 2026 |
Jan 16, 2026 |
1 AOP
|
| 3712 |
1417: NFE2/Nrf2 repression |
1445: Increase, LPO |
Jan 19, 2026 |
Jan 19, 2026 |
1 AOP
|
| 3713 |
1445: Increase, LPO |
902: Inflammation, Liver |
Jan 19, 2026 |
Jan 19, 2026 |
1 AOP
|
| 3714 |
1985: Increased Kisspeptin levels in AVPV |
1047: Increased, secretion of GnRH from hypothalamus |
Jan 29, 2026 |
Jun 2, 2026 |
4 AOPs
|
| 3715 |
1047: Increased, secretion of GnRH from hypothalamus |
2137: Increase, Gonadotropins concentration in plasma |
Jan 29, 2026 |
Jun 2, 2026 |
4 AOPs
|
| 3716 |
2137: Increase, Gonadotropins concentration in plasma |
2402: Increased, E2 production in ovaries |
Jan 29, 2026 |
Jun 2, 2026 |
4 AOPs
|
| 3717 |
2402: Increased, E2 production in ovaries |
2294: Plasma E2, increased |
Jan 29, 2026 |
Jun 2, 2026 |
4 AOPs
|